Prout Samantha's Form 4 filing
Amicus Therapeutics, Inc. (FOLD) · filed Aug 11, 2023
- Accession no.
- 0001209191-23-045479
- Filed
- Aug 11, 2023
- Trade date
- Aug 9, 2023
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Checked
This filing lists 5 non-derivative transactions and 4 derivative transactions. Open-market sales total $517.1K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Prout SamanthaCIK 0001743122 | Officer (Chief Accounting Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 9, 2023 | Common Stock | MOption exerciseAcquired | +2,376 | $10.04 | +$23,855.04 | 139,379 | Direct | |
| Aug 9, 2023 | Common Stock | MOption exerciseAcquired | +5,040 | $9.55 | +$48,132 | 144,419 | Direct | |
| Aug 9, 2023 | Common Stock | MOption exerciseAcquired | +10,592 | $10.03 | +$106,237.76 | 155,011 | Direct | |
| Aug 9, 2023 | Common Stock | MOption exerciseAcquired | +18,901 | $12.11 | +$228,891.11 | 173,912 | Direct | |
| Aug 9, 2023 | Common Stock | SSaleDisposed | −36,909 | $14.01F1 | −$517,095.09 | 137,003 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 9, 2023 | Common Stock | MOption exerciseDisposed | −2,376 | $0.00 | $0 | 0 | Direct | |
| Aug 9, 2023 | Common Stock | MOption exerciseDisposed | −5,040 | $0.00 | $0 | 2,526 | Direct | |
| Aug 9, 2023 | Common Stock | MOption exerciseDisposed | −10,592 | $0.00 | $0 | 3,176 | Direct | |
| Aug 9, 2023 | Common Stock | MOption exerciseDisposed | −18,901 | $0.00 | $0 | 37,810 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F1
This price is the weighted average price for the transactions reported on this line. The prices for the transactions reported on this line range from $14.00 to $14.10 inclusive. The reporting person undertakes to provide, upon request, by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Referenced by the price of 1 transaction in Table I.
Remarks
All transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 1, 2023.